TerluminaRX
  • Home
  • Why Terlumina | Rx?
  • Blog
  • Contact
Select Page

Compounders Pathways for BUDS in Revised USP <797> Chapter

by Rich | Feb 1, 2024 | Pharmacy, Sterile Compounding, USP

The revised USP General Chapter <797> offers compounders pathways for extended beyond-use dates (BUDs) in sterile preparations, with increasing BUDs tied to stricter requirements. Compliance is emphasized as a continuous journey, according to Kevin Hansen, PharmD....

Latest News

  • Boost Compliance & Operational Efficiency in Pharmacy with Terlumina | Rx Compliance Platform! 🚀November 6, 2024
  • Introducing Terlumina | Rx 17x Version DemoOctober 8, 2024
  • Understanding USP Chapter Regulations in the US: A Comprehensive OverviewSeptember 12, 2024
  • White Paper: How USP Standards are RegulatedSeptember 12, 2024
  • USP Compliance in Pharmacy: Understanding State Inspections in Relation to USP Guidelines P4.August 27, 2024
  • USP Compliance In Pharmacy: How JCO and ACHC Survey Pharmacies P3.August 20, 2024
  • USP Compliance in Pharmacy: Federal Oversight P2.August 6, 2024
  • USP Compliance in Pharmacy: Federal Oversight P1.August 2, 2024
  • Introduction to USP Compliance in Pharmacy: Insights and Best PracticesJuly 24, 2024
  • Compliance Safety Nets: From Zip Line Adventures To Pharmacy SolutionsJuly 2, 2024

Get In Touch

ï–Ÿ

3290 Mayflower Ave, Ste 100
Lehi, UT 84043

ï‚•

(801) 823-0923


contact@terluminarx.com

Copyright © 2024 TerluminaRx, LLC        All Rights Reserved

Quick Links

Why Terlumina | Rx?
Careers
Contact Us
Knowledge Center
Terlumina.com